Survey: 79% of consumers would consider genetic testing to limit drug side effects

Posted on November 10, 2017

More Articles

Reinsurer SCOR Offering Cancer Genomic Testing as Benefit for Policyholders, Life Insurance Clients _ Precision Oncology News

17 Nov at 11:11 pm

SCOR to Offer Wamberg Genomic Advisors’ Cancer Guardian™ Product to Life Insurance Policyholders

29 Oct at 4:16 pm

GENOME WEB – Wamberg Genomic Advisors Launched to Provide Easy Access to Affordable Genomic Testing

20 Aug at 8:38 pm

Menu